Detection of Doxycycline Using Carbon Quantum dots as Probe Based on Internal Filtering Effect
Journal of Fluorescence · 2024-05 · 34 (3) · 1353-1363
DOI: 10.1007/s10895-023-03373-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Fluorescence, online erschienen am 02.08.2023. Verfasst von Jianhou Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, 362000, China. Hauptthemen laut MEDLINE: Quantum Dots, Doxycycline, Carbon, Spectrometry, Fluorescence. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: the Quanzhou City Science & Technology Program of China, the Youth independent innovation project incubation project of the 900th Hospital of Joint Logistics Team of the PLA, the National Science Foundation of Fujian Province.
Abstract (Originalsprache)
The establishment of a convenient and effective detection method for doxycycline (DC) holds significant importance in drug monitoring and drug residue assessment. In this work, carbon quantum dots (CQDs) with excellent and stable luminescence performance (the quantum yield of CQDs was 21.8%) were synthesized by the melting method and employed as probes to monitor the fluorescence intensity variations before and after the introduction of DC. A fluorescence analytical method based on the internal filtration effect (IFE) was developed for DC determination. The mechanism of DC quenching CQDs was verified using fluorescence lifetime tests, absorption spectroscopy, and evaluation of internal filtration parameters. After optimizing experimental conditions, it was found that the DC concentration (CDC) exhibited a good linear relationship with the fluorescence quenching efficiency ((F0-F)/F0) of CQDs in the range of 5-30 µM. The fitted linear equation was Y = 0.01249*CDC+0.03625, R2 = 0.9987, and the detection limit was 2.343 µM (n = 8). This developed method has been successfully applied to accurately determine DC concentrations in both doxycycline hydrochloride tablets and human serum samples. It stands out for its simplicity, rapidity, and acceptable detection performance. Due to its advantages, this method holds great promise for application in the biomedical field for monitoring DC drug concentrations and ensuring quality control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, 362000, China.
- Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
- Department of Pharmacy, the 900th Hospital of China Joint Logistics Support Force, Fuzhou, 350025, China.
- Department of Pharmacy, the 900th Hospital of China Joint Logistics Support Force, Fuzhou, 350025, China. monday0796@163.com.
Förderung
- the Quanzhou City Science & Technology Program of China
- the Youth independent innovation project incubation project of the 900th Hospital of Joint Logistics Team of the PLA
- the National Science Foundation of Fujian Province
Zitieren
APA
Huang, J., Zhang, M., Huang, J., Deng, X., Zhang, X., Miao, C., & Weng, S. (2024). Detection of Doxycycline Using Carbon Quantum dots as Probe Based on Internal Filtering Effect. Journal of Fluorescence, 34(3), 1353-1363. https://doi.org/10.1007/s10895-023-03373-2
Vancouver
Huang J, Zhang M, Huang J, Deng X, Zhang X, Miao C, et al. Detection of Doxycycline Using Carbon Quantum dots as Probe Based on Internal Filtering Effect. Journal of Fluorescence. 2024;34(3):1353-1363. doi:10.1007/s10895-023-03373-2
BibTeX
@article{Huang2024,
author = {Huang, Jianhou and Zhang, Menghan and Huang, Jiyue and Deng, Xiaoqin and Zhang, Xintian and Miao, Chenfang and Weng, Shaohuang},
title = {Detection of Doxycycline Using Carbon Quantum dots as Probe Based on Internal Filtering Effect},
journal = {Journal of Fluorescence},
year = {2024},
volume = {34},
number = {3},
pages = {1353--1363},
doi = {10.1007/s10895-023-03373-2}
}
EUVIMED